NEWS

WIRES

OTHER

Research and Markets: Epigenetics - Global Strategic Business Report

This report analyzes the Global market for Epigenetics in US$ Million by the following Application Areas: Drug Discovery, Diagnostics, and Others. Annual forecasts are provided for the period 2006 through 2015. The report profiles 39 companies including many key and niche players worldwide such as Celgene Corporation, CellCentric Ltd., CellCentric Ltd., Epigentek Group, Inc., Genpathway, Inc., Merck & Co., Inc., MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion Genomics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary 1. INDUSTRY OVERVIEW 2. GLOBAL MARKET OVERVIEW 3. COMPETITION 4. PRODUCT OVERVIEW 5. PRODUCT LAUNCHES 6. RECENT INDUSTRY ACTIVITY 7. RECENT RESEARCH FINDINGS 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE

III. COMPETITIVE LANDSCAPE Total Companies Profiled: 39 (including Divisions/Subsidiaries - 42) Some Companies Mentioned:

• Celgene Corporation (US)
• CellCentric Ltd. (UK)
• Epigenomics AG (Germany)
• Epigentek Group, Inc. (US)
• Genpathway, Inc. (US)
• Merck & Co., Inc. (US)
• MGI Pharma, Inc. (US)
• Millipore Corporation (US)
• OncoMethylome Sciences S.A (Belgium)
• Orion Genomics (US)

For more information visit http://www.researchandmarkets.com/research/ff2bff/epigenetics_glob

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716